Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Head and Neck Cancers
•
Radiation Oncology
Do you modify your treatment strategies for P16 positive oropharyngeal cancers in patients who also have a significant smoking history?
Related Questions
In what cases of T3N0 glottic SCC, would you omit chemotherapy and offer radiation alone?
For a small (<5 mm) hard/soft palate junctional primary with DOI <2 mm status post limited excision with negative but close deep margin, how would you approach neck management in the adjuvant RT setting?
When treating sinonasal undifferentiated carcinoma (SNUC) with induction chemotherapy followed by definitive chemoradiation, do you include the entire pre-chemo volume in your high-dose CTV?
In a patient with bilateral neck level II small cell carcinoma with no apparent primary after workup with plans to receive concurrent cisplatin/etoposide, what would be your treatment volumes?
How do you manage a patient who finished chemoRT for head and neck cancer and loses >10% body weight within 2 weeks post-treatment?
Do you have a preference between using 2 dose levels (5940/6996) versus 3 dose levels (5700/6300/6996) for NPC, EBV+ and why?
How would you determine ipsilateral vs bilateral neck irradiation for early stage, well lateralized nasal cavity SCC?
What dose are you routinely using for adjuvant RT for intermediate risk p16+ SCC of the OPX s/p TORS?
What is your approach for treating oligometastatic head and neck cancer to an adjacent nodal site (ie. axilla, mediastinum etc.) with radiation therapy?
How would you manage the contralateral neck and adjacent structures for a glossotonsillar or glossopharyngeal sulcus primary cancer if well lateralized?
